Spark Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersPhiladelphia, PA
US patents7
SAM.gov UEIFQ9CFQFD6MP6
CAGE code7CUR0
Incorporated inDE
LEI549300EZ6EOPQBLJNB93
- Patient Support Services
- Genentech Patient Foundation
- Population Health
- Clinical Trials
- Medicine Information Support
- Disease Education
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
7 US patents granted 2020–2025, 6 of them in the five years to SEP 2025.
Pharmaceuticals 3Biotechnology 2Chemical engineering 2
- Enhancing agents for improved cell transfection and/or rAAV vector productionUS 12,404,526 · granted SEP 2, 2025
- Relative potency assay for viral vector encoding isomerohydrolasesUS 12,359,239 · granted JUL 15, 2025
- Optimized promoter sequences, intron-free expression constructs and methods of useUS 12,290,574 · granted MAY 6, 2025
- Codon-optimized acid alpha-glucosidase expression cassettes and methods of using sameUS 12,084,693 · granted SEP 10, 2024
- Column-based fully scalable rAAV manufacturing processUS 11,702,639 · granted JUL 18, 2023
Newest 5 shown · Granted to Spark Therapeutics, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Spark Therapeutics INC. | Philadelphia | PA | — | UNVERIFIED |
| Spark Therapeutics, INC. | Philadelphia | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.